Description

• Application: Comparison of passive targeted delivery of inorganic and organic nanocarriers among different types of tumors.: This study compares the efficiency of calcium carbonate-based nanocarriers in targeted drug delivery across various tumor types, offering insights into their potential for enhancing cancer treatment efficacy (Postovalova et al., 2024).
• Analysis Note: Assay (complexometric; calculated on dried substance): 98.5 - 100.5 %Identity: passes testSubstances insoluble in acetic acid: ≤ 0.2 %Substances insoluble in hydrochloric acid: ≤ 0.005 %Chloride (Cl): ≤ 0.005 %Sulfate (SO₄): ≤ 0.03 %Heavy metals (as Pb): ≤ 0.002 %Total nitrogen (N): ≤ 0.001 %Al (Aluminium): ≤ 0.005 %As (Arsenic): ≤ 0.0004 %Ba (Barium): passes testCu (Copper): ≤ 0.0005 %Fe (Iron): ≤ 0.001 %K (Potassium): ≤ 0.005 %Mg (Magnesium): ≤ 0.02 %Na (Sodium): ≤ 0.2 %Pb (Lead): ≤ 0.0005 %Sr (Strontium): ≤ 0.1 %Magnesium and alkali metals: ≤ 1.5 %Particle size (d 50): about 14 µmLoss on drying (200 °C): ≤ 1.0 %Corresponds to Reag. Ph Eur
• Legal Information: EMSURE is a registered trademark of Merck KGaA, Darmstadt, Germany